Introduction

In the vast canvas of organic chemistry, the allure of pyrimidone derivatives beckons researchers with the promise of unlocking new frontiers in biological applications. This class of compounds, distinguished by the presence of the pyrimidine nucleus, a cornerstone in medicinal chemistry, stands as a crucial pharmacophore, with the synthesis of novel derivatives emerging as a focal point in contemporary drug discovery [1-3]. This dynamic pursuit is not merely a scientific endeavor but an artistic exploration into the realms of potential therapeutic advancements. Within the intricate molecular design, the synthesis of innovative pyrimidine derivatives takes center stage, captivating the imagination of researchers as they endeavor to craft compounds that transcend the ordinary.

Biginelli adducts have demonstrated notable biological properties encompassing calcium channel inhibition, antioxidant, antiviral, antimicrobial, antitubercular, and anti-inflammatory activities [4- 7]. The therapeutic potential of dihydropyrimidinones has prompted the exploration of modified techniques for the Biginelli reaction. The initial approach involves a one-pot, multicomponent reaction involving benzaldehyde, ethyl acetoacetate, and urea in ethanol under reflux conditions with the presence of HCl, yielding the desired Biginelli adduct. Although several methodologies have been developed in recent years, many suffer from limitations such as harsh conditions, extended reaction times, low yields, and the use of expensive catalysts, making them less compatible with green chemistry principles [8-11].

An essential focus in recent catalysis research revolves around green reaction media [12, 13]. Metal oxide nanoparticles have demonstrated the ability to catalyze various organic transformations on their active surfaces and interstitial cavities [14, 15]. PEG-400 has emerged as a green, benign, and recyclable solvent, serving both as a solvent and catalyst for numerous reactions [16, 17]. Ongoing efforts are dedicated to devising methods for the synthesis of diverse organic compounds [18, 19]. The utilization of ultrasound and microwave methods is noteworthy for their safety and efficiency in terms of reaction time [20, 21]. In view of the above, in the present work, aryl substituted dihydro pyrimidone was synthesized using the green synthesis method and is estimated to have photophysical and biological applications.

Materials and Methods

The urea, thiourea, N-methyl urea, anisaldehyde, salicylaldehyde, p-chlorobenzaldehyde, p-nitrobenzaldehyde and p-fluorobenzaldehyde were sourced from Spectro Chem and employed following the manufacturer instructions. The chemical reactions were conducted under standard atmospheric conditions. Thin-layer chromatography plates composed of silica gel were used, and ethyl acetate in hexane served as the mobile phase for monitoring the reaction. Melting points were determined using open capillaries and a melting point apparatus. Tetramethyl silane (TMS) was used as an internal reference for 1H-NMR spectra, which were acquired using a Jeol (400 MHz) nuclear magnetic resonance spectrometer with DMSO-d6 as the solvent. Chemical shift values are reported in delta (parts per million, ppm). HPLC and mass analysis of the resulting compounds were performed using a 1290 Infinite UHPLC instrument. The synthesized compounds’ infrared spectra (4000-350 cm-1) were captured in KBr pellets using a Bruker IR spectrophotometer.

Synthesis of the Aryl Substituted Dihydro Pyrimidone Derivative

The aryl substituted dihydro pyrimidone derivative was synthesized using the one pot synthesis method (Fig. 1). Initially, a combination of aromatic aldehydes (20 mmol), along with urea/thiourea/methyl urea (20 mmol) and ethyl acetoacetate (20 mmol), was subjected to reflux in ethanol in the presence of a catalytic amount of concentrated hydrochloric acid for 2 hours. Following confirmation of reaction completion through thin-layer chromatography, the reaction mixture was cooled and introduced to crushed ice water. The resulting solid product was filtered and washed with water, and the crude product underwent recrystallization with ethanol. Further, the identical derivative was produced using an environmentally friendly synthesis method. Initially, both grapefruit (Citrus maxima) and dessert lime (Citrus medica) underwent thorough washing and were subsequently dried by patting. Afterward, the fruits were halved. The extraction process involved using a citrus juice squeezer for the dessert lime and gently pressing the grapefruit halves with a pestle and mortar. The grapefruit juice was then filtered through cotton to obtain a clear solution. For the synthesis, separate round-bottom flasks were used to contain 20 mmol of aromatic aldehydes, 20 mmol of ethyl acetoacetate, and 20 mmol of urea. Natural catalysts (Citrus maxima or Citrus medica) were introduced by adding 10 mL of grapefruit juice to one flask and dessert lime juice to the other. The mixtures were stirred at room temperature for 10 to 12 hours, with TLC used to monitor the reaction’s progress. Upon completion, the reaction mixtures were filtered and washed with water, and the resulting solid product underwent recrystallization with ethanol. All synthesized compounds were subsequently confirmed through FTIR, 1H-NMR, and mass spectroscopy and are given in Fig. S1-28.

Fig. 1.

Synthesis of the aryl substituted dihydro pyrimidone.

https://www.pjoes.com/f/fulltexts/183851/PolJEnvironStud-2024-33-5-5549-5556_Fig_1_min.jpg

Structural Data of Aryl Substituted Dihydro Pyrimidone.

Ethyl-6-methyl-2-oxo-4-phenyl-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P1)

Melting point: 198ºC, Percentage yield: 84%.1H-NMR (DMSO-d6, 400 MHz): δ ppm 9.2 (s, 1H), 7.7 (m, 1H), 7.2-7.4 (m, 5H), 5.1 (s, 1H), 3.9 (q, 3H), 2.2 (s, 3H), 1.1 (t, 3H). High Resolution MS: m/z 261.12. HPLC purity was found to be: 91.70 %. IR (KBr, cm-1): 3200-3100 (N-H stretching), 1750-1700 (C=O of ester), 1650 (C=O of amide).

Ethyl-4-(4-chlorophenyl)-6-methyl-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P2)

Melting point: 224ºC, Percentage yield: 80%. 1H-NMR (DMSO-d6, 400 MHz): δ ppm 9.2 (s, 1H), 7.8 (m, 1H), 7.4 (m, 2H), 7.2 (m, 2H), 5.1 (s, 1H), 3.9 (q, 3H), 2.2(s, 3H), 1.1(t, 3H). High Resolution MS: The mass of the compound was found to be 295.28 g/mol.HPLC purity was found to be 92.66%. IR (KBr, cm-1 3200-3100 (N-H stretching), 1750-1700 (C=O of ester), 1650 (C=O of amide).

Ethyl 4-(4-fluorophenyl)-6-methyl-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P3)

Melting point: 164ºC, Percentage yield: 84%, 1H NMR (DMSO-d6, 400 MHz): δ ppm 9.2 (s, 1H), 7.8 (S, 1H), 7.3 (m, 2H), 7.1 (m, 2H), 4.0 (q, 3H), 2.2 (S, 3H), 1.1 (t, 3H), 5.1 (s, 1H), High Resolution MS: The mass of the compound was found to be 279.11 g/mol HPLC purity was found to be 97.99 %. IR (KBr, cm-1) 2918, 2825, 1597, 1387, and 483.

Ethyl-4-(4-methoxyphenyl)-6-methyl-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P4)

Melting point: 188ºC, Percentage yield: 83%, 1H-NMR (DMSO-d6, 400MHz): δ ppm 9.2 (s, 1H), 7.7 (m, 1H), 7.1 (m, 2H), 6.8 (m,2H), 5.1 (m,1H), 3.9 (q,2H), 3.8 (S,3H), 2.2 (s, 3H),1.1 (t, 3H) High Resolution MS: The mass of the compound was found to be 291.13 g/mol, HPLC purity was found to be 94.63 %. IR (KBr, cm-1) 2936, 2832, 1677, 1605, and 1237.

Ethyl-4-(2-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P5)

Melting point: 190ºC, Percentage yield: 82%, 1H-NMR (DMSO-d6, 400MHz): δ ppm 9.6 (s, 1H), 9.1 (s, 1H), 7.1-7.4 (m, 4H), 5.4 (s,1H), 4.1 (q,1H), 3.9 (q, 2H), 2.2 (S, 3H), 1.0 (t, 3H) High Resolution MS: The mass of the compound was found to be 276.11 g/mol. HPLC purity was found to be 89.98%. IR (KBr, cm-1) 3440, 3119, 2993, 1689, 1593, and 1117.

Ethyl-6-methyl-4-phenyl-2-sulfanylidene-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P6)

Melting point: 170ºC, Percentage yield: 92%, 1H-NMR (DMSO-d6, 400MHz): δ ppm 10.3 (s, 1H), 9.6 (s, 1H), 7.3 (m, 5H), 5.1 (s, 1H), 4.0 (m, 2H), 2.2 (s, 3H), 1.1 (t, 3H). High Resolution MS: The mass of the compound was found to be 277.10g/mol. HPLC purity was found to be 83.9 %. IR (KBr, cm-1) 2975, 2832, 1592, and 1371.

Ethyl-1,6-dimethyl-2-oxo-4-phenyl-1,2,3,4- tetrahydropyrimidine-5-carboxylate (P7)

Melting point: 168ºC, Percentage yield: 90%, 1H-NMR (DMSO-d6, 400MHz): δ ppm 8.0 (s, 1H), 7.3 (m, 2H), 7.2 (m, 3H), 5.1 (s,1H), 4.0 (m, 2H), 3.1 (s, 3H), 2.5 (s, 3H), 1.1 (t, 3H). High Resolution MS: The mass of the compound was found to be 275.13g/mol, HPLC purity was found to be 95.25%. IR (KBr, cm-1) 2971, 2822, 2722,1577 and 1333.

Results and Discussion

The molecular structure and reactant used for the reaction are given in Table 1. The molecular structure of the 1H-NMR spectra of derivatives P1-P7 was recorded in DMSO-d6, as depicted in Fig. S1-7. In P1, a sharp singlet at δ: 2.2 ppm indicated the presence of a methyl substituent attached to a pyrimidine ring. Methylene (-CH2-) and methyl (-CH3-) groups linked with oxygen [-O(CH2CH3)] resonated at δ:3.9 ppm and δ:1.1 ppm, respectively, as a quartet and triplet. Singlets at δ:5.1 and 9.2 ppm provided insight into the -NH protons in the pyrimidine architecture, while aromatic protons resonated as a multiplet in the range δ:7.2-7.4 ppm. In molecule P2, a singlet peak at δ:2.2 ppm corresponded to free methyl, and singlets at δ:9.2 ppm and δ:7.3 ppm were attributed to the -NH moiety in the six-membered heterocyclic ring. Methylene and methyl protons in [-O(CH2CH3)] resonated at δ:4.0 and δ:1.1 ppm as a quartet and triplet, respectively. Aromatic peaks in the range δ:7.1 to 7.3 ppm appeared as multiplets. Molecule P3 exhibited sharp singlets at δ:2.23 ppm, δ:9.2 ppm, and δ:7.3 ppm for free methyl and two -NH moieties attached to the six-membered heterocyclic pyrimidine architecture, respectively. The ethyl moiety in [-O(CH2CH3)] resonated as a quartet and triplet at δ:4.0 and δ:1.1 ppm. Aromatic protons displayed multiplets in the range δ:7.1 to 7.3 ppm. In molecule P4, two -NH protons resonated as singlets at δ:9.2 ppm and δ:7.1 ppm, while methyl groups resonated at δ:2.2 ppm and δ:3.8 ppm as a singlet, indicating methyl and methoxy substitution. Methylene and methyl groups [-O(CH2CH3)] resonated at δ:3.9 ppm and δ: 1.1 ppm, respectively. Aromatic protons appeared as a multiplet in the range δ:6.8-7.1 ppm. Derivative P5 displayed singlets at δ:9.6 ppm, δ:9.1 ppm, and δ:2.2 ppm for two -NH and a methyl substitution, respectively. Methylene and methyl groups [-O(CH2CH3)] resonated as a quartet and triplet at δ:3.9 and δ:1.0 ppm. Aromatic protons in the region δ:7.1-7.4 ppm indicated their presence as a multiplet. P6 exhibited singlets at δ:10.3, δ:9.6, and 2.2 ppm for two -NH and a free methyl group. Quartet and triplet peaks at δ:4.0 and δ:1.1 ppm corresponded to methylene and methyl groups [-O(CH2CH3)], and aromatic protons resonated in the range δ:7.1-7.3 ppm as a multiplet. Molecule P7 showed singlets at δ:8.0 ppm, δ:3.1 ppm, and δ:2.5 ppm for -NH, -NCH3, and free methyl groups, respectively. Methylene and methyl groups [-O(CH2CH3)] resonated as a quartet and triplet at δ:4.0 and δ:1.1 ppm. Aromatic protons were multiplets in the region δ:7.2-7.3 ppm. Additionally, all synthesized derivatives exhibited a junction -CH at δ:5.1 ppm - 5.4 ppm as a singlet. The FT-IR spectra of the synthesized mono-azo derivatives revealed valuable information about the functional groups, explaining the characteristics of stretching modes of vibration for the azo molecules. HPLC and mass analysis of the resulting compounds P1-P7 were investigated and assigned (Fig. S8-22). Fig. S23-28 depicts the FT-IR spectra, with bands at 3246 cm-1 indicating the presence of –NH groups. Another band at 1726 cm-1 was attributed to the –C=O functional group in the cyclic ring moiety, and –C-O functionality was displayed at 1117 cm-1. The synthesized derivatives displayed aromatic –CH stretching bands in the region 3100-2800 cm-1, and 1670-1650 cm-1 were related to –CONH groups. Aromatic substituted halides showed Ar-X in the range of 1000-500 cm-1.

Computational Photo Physical Studies

In this study, Gaussian 16 software was employed for a comprehensive computational investigation into the synthesized molecules. The optimization of ground-state geometry was meticulously conducted using the DFT-B3LYP-6-31G(d) basis set. The resulting HOMO-LUMO energy levels, derived from the optimized geometry, were quantified and meticulously recorded in Table 1. The calculated HOMO and LUMO values, expressed in electron volts (eV), facilitated a thorough assessment of the band gap for the synthesized compounds, as systematically presented in Table 2.

Remarkably, the designed compounds (denoted as P1 to P7) featuring distinct positional groups displayed a narrowed energy gap when compared to molecule P5. The latter, characterized by a highly electronegative bromobenzene attached to the main moiety, underscored the substantial influence of functional group types on the energy gap of the molecules. Specifically, molecule P5 exhibited the smallest energy band gap, attributed to the presence of the phenol unit, as meticulously outlined in Table 2. The ranking of the energy band gap for all examined molecules unfolded as follows: P1>P4>P7>P3>P2>P6>P5. Overall, the theoretically predicted molecules demonstrated an enhanced capacity for charge transfer between molecular orbitals, thereby indicating their potential suitability for diverse biological applications [22, 23].

To gain a deeper understanding of the molecular orbitals (MOs) in the designed molecules, an assessment of the distribution of frontier molecular orbitals (FMOs) was undertaken. Detailed contour plots of the frontier orbitals HOMO and LUMO for the molecular systems are thoughtfully presented in Table 2. The density of HOMO and LUMO elegantly spans across the 6-methyl- 4-phenyl-3,4-dihydropyrimidin-2(1H)-one group. The perfect superposition of these diminutive donor candidates highlights their intriguing properties for facilitating electron transport from the HOMO to the LUMO orbital.

In our quest for insights into the chemical reactivity and stability of the synthesized molecules, global reactivity parameters were calculated. These global chemical reactivity descriptor (GCRD) parameters encompass chemical hardness (η), electronegativity (χ), chemical potential (μ), chemical softness (S), and electrophilicity index (ω) and the equation involved in the GCRD parameter is given supplementary information. The ionization potential (IP) and electron affinity (EA) were pivotal in these calculations. The resulting global reactivity parameters are meticulously detailed in Table 3.

Chemical hardness (η=(IP−EA)/2)

Electronegativity (χ=(IP+EA)/2)

Chemical potential (μ=−χ)

Chemical softness (S=1/2η)

Electrophilicity index (ω=μ2/2η)

Ionization potential, IP=−EHOMO

Electron affinity, EA=−ELUMO.

A lower ionization potential (IP) coupled with a higher electron affinity (EA) signals a robust electron transport capability. From the findings presented in Table 2, the ionization potential (IP) values traverse a range from 6.110 eV to 5.646 eV in the following order: P6>P2>P3>P1>P4>P7>P5. Compound P7 emerges with a lower IP value, indicating its relatively diminished electron donor capability among the studied compounds. Meanwhile, the electron affinity (EA) values, spanning from 1.238 eV to 1.743 eV, showcase P6 with the maximum EA value, underscoring its superior electron transport capability. The pursuit of enhanced charge transfer and separation emphasizes the significance of a small chemical hardness (η) value. Notably, from Table 2, molecule P5 stands out with the lowest chemical hardness among the studied molecules. Further exploration into the stabilization energies of the molecular structures, measured by the electrophilicity index (ω), reveals that the designed molecule P6 exhibits the highest electron-accepting power and stabilization energy among its counterparts, an attribute attributed to the presence of chlorobenzene [24]. This comprehensive analysis sheds light on the intricate molecular landscape and paves the way for further exploration of these compounds in diverse applications.

Table 1.

List of the aryl substituted dihydro pyrimidone.

CompoundAldehyde R1X/R2ProductYield
P1HO/HO O NH HN O84%.
P24-ClO/HCl O O NH HN O80%
P34-FO/HF O O NH HN O84 %
P44-OCH3O/HO O O NH HN O83%
P52-OHO/HO OH O NH HN O82 %
P6HS/HO O NH HN S92 %
P7HO/CH3O O NH N O90 %
Table 2.

GCRD parameters obtained from HOMO-LUMO and dipole moment of newly synthesized compounds (P1-P7).

SampleEHOMO (eV)ELUMO (eV)ΔE (eV)IP (eV)EA (eV)η (eV)χ (eV)μ (eV)S (eV-1)ω (eV)
P1-5.831-1.3344.4975.8311.3342.2483.583-3.5830.2222.855
P2-5.974-1.5744.4005.9741.5752.2003.775-3.7750.2273.238
P3-5.942-1.5074.4355.9421.5082.2183.725-3.7250.2253.129
P4-5.706-1.2454.4615.7061.2462.2303.476-3.4760.2242.709
P5-5.646-1.4264.2195.6461.4272.1103.536-3.5360.2372.964
P6-6.110-1.7434.3676.1101.7432.1843.927-3.9270.2293.531
P7-5.678-1.2374.4415.6781.2382.2203.458-3.4580.2252.693

In vitro Antimicrobial and Antifungal Activity

We conducted antimicrobial and antifungal studies on the recently synthesized molecules, denoted as (P1-P7). Significantly, compounds P4 and P5 displayed notable antibacterial efficacy against S. aureus, B. subtilis, S. typhi, E. coli, A. niger, and C. Albicans. The heightened activity of these compounds is likely attributed to the presence of biologically active anisole and phenol groups attached to the pyrimidone in P4 and P5. Fluorine, being the second-smallest substituent, shares similarities with hydrogen in terms of steric requirements at enzyme receptor sites. The incorporation of fluorine has been shown to enhance absorption rates by increasing lipid solubility [25]. The highly lipophilic nature of the trifluoromethyl group plays a significant role in improving pharmacological activity. Conversely, the remaining molecules exhibited minimal antibacterial activity [26]. Detailed data for all other molecules with moderate antibacterial activity are presented in Table 3. All other compounds demonstrated moderate activity; data and minimum inhibitory concentrations (MIC) are provided in Table 3’s parenthesis.

Conclusions

In summary, we have successfully demonstrated a convenient green chemistry method for synthesizing a diverse range of aryl-substituted dihydropyrimidone derivatives (P1-P7). The synthesized compounds were characterized using spectral and analytical methods. HOMO-LUMO energy levels were estimated through the DFT-B3LYP-6-31G(d) basis set within the Gaussian- 09W software. GCRD parameters were derived from the theoretically estimated HOMO-LUMO energy levels, revealing that P4 and P5 exhibit highly electrophilic behavior. Moreover, the antibacterial and antifungal activities of the synthesized molecules were assessed against S. aureus, B. subtilis, S. typhi, E. coli, A. niger, and C. albicans. The biological application results indicate that P4 and P5 molecules exhibit potent antibacterial and antifungal behavior.

Table 3.

Antimicrobial and antifungal activity of the aryl substituted dihydro pyrimidone derivatives.

CompoundsS. aureusB. subtilisS. typhiE. coliA. nigerC. albicans
P1192018172021
P2212319202118
P3212422242321
P4212621262627
P5222726272725
P6202221221822
P7232122192124
Standarda252523252324
Controlb DMSO000000

[i] Note: aStandard drugs employed were Ciprofloxacin (40 µg in 100 μL) for bacteria and Fluconazole (40 µg in 100 μL) for fungi. The tested compounds were utilized at concentrations of 40 µg in 100 μL, and the corresponding measurements of zone of inhibition were expressed in millimetres, bControl: DMSO (Dimethyl sulphoxide).